Life Sciences Year End Review – Implications of 2023 Regulatory and Enforcement Developments (On-Demand Webinar)

Register

Date: 01/17/24
Closed captions are available.

Overview: As you begin planning for 2024, this presentation is intended to provide you with a basic understanding of important legal developments in the life sciences industry that may affect your operations, compliance work plans, and general planning for the upcoming year. 

The presenters discuss the regulatory and enforcement developments in each area of life sciences, including pharmaceuticals, medical devices, and clinical laboratories, that took place in 2023. The presenters also touch on significant proposals, such as the FDA's proposal to regulate laboratory-developed tests, and recent FDA and FTC guidance on direct-to-consumer advertising, which can have an effect on promotional activities for life science companies. The webinar also provides an overview of changes in the anti-trust enforcement environment that may impact life sciences companies.

Learning Objectives:

  • Enhance the understanding of life science professionals regarding the latest regulatory developments affecting their businesses, fostering a collaborative learning environment to navigate evolving compliance landscapes.
  • Keep life science companies informed about recent enforcement actions, aiding proactive management of potential impacts on business and compliance.
  • Promote awareness and understanding among life science professionals of recent antitrust developments, encouraging a commitment to fair competition and ethical business practices for sustainable and inclusive industry growth.

Speaker Information:

Danielle Sloane, Member, Bass, Berry and Sims

Daryl Daly, Counsel, Bristol Myers Squibb

Seth Mailhot, Partner, Husch Blackwell

Bevin Newman, Partner, Sheppard Mullin

Continuing Education:

CLE: The maximum number of credits available for ON DEMAND is 1.5 for a 60-minute state and 1.8 for a 50-minute state. Please note that the availability of credits may vary from state to state.  This self-study course will be available for purchase for approximately one year after the recording date, but state rules on duration of eligibility for CLE-credits differ, so please check with your state before purchasing self-study offerings. 

CPE: CPE credits are not available for on-demand. 

CCB: The Compliance Certification Board (CCB)® has approved this event for up to 1.8 NON-LIVE CCB CEUs based on a 50-minute hour. Continuing Education Units are awarded based on individual attendance records. Granting of prior approval in no way constitutes endorsement by CCB of this event content or of the event sponsor. 

For additional information, please visit the AHLA Continuing Education page. 

 

Also available from AHLA: Market Access, Pricing, and Reimbursement of Drugs and Devices: Legal Principles and Practice

Register